Sat.Oct 02, 2021 - Fri.Oct 08, 2021

article thumbnail

Pharmacy Technician Education and Hearing Difficulty

Pharmacy Tech Scholar

Pharmacy Technician Education for Deaf and Hard of Hearing Our work is driven by our mission and vision. We help people become pharmacy technicians, and… The post Pharmacy Technician Education and Hearing Difficulty appeared first on PharmacyTechScholar.com.

221
221
article thumbnail

Devoted Health closes $1.15B series D funding round

Fierce Healthcare

Devoted Health closes $1.15B series D funding round. pminemyer. Fri, 10/08/2021 - 14:49.

145
145
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Twin Health raises $140m for “digital twin” diabetes reversal app

pharmaphorum

The developer of a toolkit that promises to create a “digital twin” of individuals with chronic metabolic diseases like diabetes to help model the impact of lifestyle changes has secured $140 million in funding to develop the technology. US and India-based Twin Health says the Whole Body Digital Twin platform uses Internet of Things (IoT) sensors and self-reported data within an artificial intelligence-driven software platform to generate a virtual copy of a person’s unique met

FDA 143
article thumbnail

Open Source “Wikipedia” for Drug Discovery

Pharma Mirror

By Kambiz Shekdar, Ph.D. Open source drug discovery was proposed in the past in connection with third-world diseases like tuberculosis and malaria, but it is in the context of first-world indications where it is needed most. Despite untold investment by numerous pharmaceutical companies, FDA-approved drugs that target critical brain functions and conditions like anxiety, depression, and sedation continue to present severe and unpredictable side effects, including suicidal ideation.

article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

Informatics useful in advancing personalized medicine: Washington University

Outsourcing Pharma

A representative from the school explains how tools like artificial intelligence and natural language processing can help elevate personalized medicine.

105
105
article thumbnail

Women's digital health rakes in $1.3B in 2021 buoyed by investor interest in more integrated care

Fierce Healthcare

Women's digital health rakes in $1.3B in 2021 buoyed by investor interest in more integrated care. hlandi. Mon, 10/04/2021 - 12:56.

145
145

More Trending

article thumbnail

CPhI Worldwide: 9-11 November 2021 in Milan, Italy

Pharma Mirror

“In a year when literally hundreds of our exhibitors have contributed to overcoming COVID, the greatest healthcare challenge of recent times, we are delighted to be welcoming back the pharma community. CPhI Worldwide is an essential conduit in helping pharma supply chains work, partners meet, empowering the industry with learning. But this year, more than ever, the event will also be a celebration of everything pharma has achieved.

98
article thumbnail

Three Ways Pharma Advertisers Can Benefit from Attention Metrics

Pharma Marketing Network

By: Marc Guldimann, Co-founder and CEO, Adelaide. Targeting and attribution challenges are universal, but pharmaceutical advertisers encounter several unique hurdles with digital advertising. Given their often niche content, pharma marketers must target smaller, more exclusive audiences to drive results while developing impactful creative. Reaching these audiences is further complicated by HIPAA and FTC regulations — not to mention international laws like GDPR and the gradual deprecation of thir

HIPAA 98
article thumbnail

Gearing up to go public, Babylon CEO outlines the company's long-term game in digital health

Fierce Healthcare

Gearing up to go public, Babylon CEO outlines the company's long-term game in digital health. hlandi. Mon, 10/04/2021 - 20:06.

145
145
article thumbnail

Transform patient experience with intelligent hyper-personalisation

pharmaphorum

Since 2019, pharmaceutical companies have been speeding to integrate digital channels and processes into their marketing efforts and patient outreach, to prepare for the wave of digitisation in the healthcare industry. As part of these efforts, customer experience (CX) became a key focus area to ensure customer engagement and loyalty. Significant strides have been made by the industry when it comes to embedding forward-thinking practices into its strategic marketing goals with healthcare profess

article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

ViiV submits FDA application for pediatric HIV treatment

Outsourcing Pharma

The HIV treatment specialist has sent an application to the agency for tolutegravir, a single-tablet treatment indicated for children living with the virus.

FDA 82
article thumbnail

First subject given COVID-19 vaccine candidate in UK-based Scancell’s COVIDITY trial

Pharma Times

UK-based Scancell Holdings has announced that its first subject has been dosed in its COVIDITY clinical trial in South Africa.

article thumbnail

Behavioral, maternal health worsening among children, women, report finds

Fierce Healthcare

Behavioral, maternal health worsening among children, women, report finds. agliadkovskaya. Thu, 10/07/2021 - 16:26.

144
144
article thumbnail

NHSX backs 14 digital health projects after funding round

pharmaphorum

NHSX, the government agency tasked with digitally transforming NHS England, has granted funding to 14 projects in its first digital health award competition. The Digital Health Partnership Award opened for applications in July and is aimed at projects that can help NHS organisations in England support patients with long term conditions focusing on supporting people at home.

Hospitals 114
article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

article thumbnail

Making the most of trial data can benefit patients: Parexel

Outsourcing Pharma

An expert from the CRO explains the evolution of data technologies put to use in clinical studies and offers advice on how to best make them work in trials.

59
article thumbnail

Fungus-derived cancer killing drug by Oxford University shows promise

Pharma Times

A chemotherapy drug, NUC-7738, which is derived from a Himalayan fungus has been found to have 40 times greater potency in killing cancer cells than its original parent compound.

article thumbnail

Q3 2021's health tech funding blows previous years out of the water

Fierce Healthcare

Q3 2021's health tech funding blows previous years out of the water. dmuoio. Thu, 10/07/2021 - 11:00.

142
142
article thumbnail

AZ files for emergency use of COVID-19 antibody combo in US

pharmaphorum

AstraZeneca has sought emergency use authorisation for its antibody combination AZD7442, following trial results indicating it can prevent symptomatic COVID-19 infection when given to healthy patients. AZD7442 (tixagevimab/cilgavimab) is the first long-acting antibody drug that has demonstrated it can be used in this way, reducing the risk of symptomatic COVID-19 by 77% compared to placebo in the recently reported PROVENT trial.

article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

Medical Writing — An Outsourcing Competency

Pharma Mirror

The history of medical writing began with the rise of the modern clinical trial. A medical writer can be your most pivotal ally in a clinical trial. While clinic directors, data managers, and investigators in the pharmaceutical industry are required for clinical trials, medical writers are the glue that holds clinical trials together. The increase in volume of clinical trials has already put a tremendous strain on journal editors and reviewers.

FDA 52
article thumbnail

MSD: Antiviral COVID-19 pill can halve the risk of hospitalisation and death

Pharma Times

MSD and Ridgeback Therapeutics announced that their investigational anti-viral medicine reduced the risk of hospitalisation and death by approximately 50% in non-hospitalised adult patients with mild-to-moderate COVID-19.

54
article thumbnail

UCHealth stands firm on denying organ transplants to patients, donors who are unvaccinated for COVID-19

Fierce Healthcare

UCHealth stands firm on denying organ transplants to patients, donors who are unvaccinated for COVID-19. dmuoio. Wed, 10/06/2021 - 14:51.

141
141
article thumbnail

Kite claims a first for CAR-T Tecartus in adult leukaemia

pharmaphorum

The FDA has approved Kite Pharma’s Tecartus as a treatment for adults with relapsed or refractory B-cell precursor acute lymphoblastic leukaemia (ALL), making CAR-T therapy an option for an entirely new group of patients. The regulator cleared Tecartus (brexucabtagene autoleucel) for the new indication after a swift review that focused on the ZUMA-3 trial , which showed that 65% of patients treated with the CAR-T went into remission from the cancer.

FDA 109
article thumbnail

Metrics make a difference in clinical research advancement: Advarra

Outsourcing Pharma

An expert from the IRB and study solutions firm explains how advanced analytics can lead to several benefits, including shortened trial startup timelines.

52
article thumbnail

AstraZeneca pursues approval for COVID-19 antibody cocktail

Pharma Times

AstraZeneca has submitted an emergency approval to the US drug regulators for its COVID-19 antibody cocktail, which would be the first non-vaccine protection from the virus to be granted approval.

article thumbnail

Telehealth use is surging but patient satisfaction with the service has declined, new study finds

Fierce Healthcare

Telehealth use is surging but patient satisfaction with the service has declined, new study finds. agliadkovskaya. Mon, 10/04/2021 - 12:54.

140
140
article thumbnail

Pfizer agrees $630m deal to harness Voyager’s gene therapy tech

pharmaphorum

Voyager Therapeutics has just landed a new gene therapy alliance with Pfizer that could go some way towards easing the pain of losing three other partners in the space of a couple of years. Pfizer is paying Voyager $30 million upfront to get access to its TRACER adeno-associated virus (AAV) vector technology, which aims to improve the safety of gene therapies – a field that has suffered a string of safety scares in the last few months.

FDA 105
article thumbnail

People on the Move: October 2021

Outsourcing Pharma

This monthâs news on appointments, expansions, acquisitions and other events includes Nanoform, Elligo Health Research, Curavit, and other organizations.

52
article thumbnail

Knowing How Your Immune System Works

Lifewell Rx Pharmacy

A person’s immune system is an extremely important defense mechanism that can identify invading organisms and consequently destroy them. The immune system can be triggered naturally or artificially. The latter is done by immunizations and vaccines. Immunization prevents diseases by enabling the body to rapidly respond to an attack and enhancing the production of an immune response via immune cells to a particular harmful organism.

article thumbnail

CMMI director hints at shift away from payment models for every episode of care, specialties

Fierce Healthcare

CMMI director hints at shift away from payment models for every episode of care, specialties. rking. Tue, 10/05/2021 - 14:40.

135
135
article thumbnail

The power of R&D collaborations to improve outcomes in rare diseases

pharmaphorum

Far more common than initially thought, rare disease treatments remain far too scarce. The answer to the problem, of course, lays in making medical research more effective. A key step towards this is great collaborative working, and partnerships with the likes of the European reference networks and French healthcare network G2M are crucial to success.

article thumbnail

Irish research centre announces major partnership with five major BioPharma companies

Pharma Mirror

Limerick, Ireland: Irish SFI-funded research centre SSPC has announced a major collaboration with five of the world’s leading BioPharma companies that aims to reduce waste, maintain standards and minimise costs in pharmaceutical processes. The rising need for early diagnosis of chronic diseases, coupled with growing demand for drugs which work better and have fewer side effects, is largely responsible for the growth of the protein A resin market.

52
article thumbnail

A Traveler’s Guide To Beating Burnout In Belize

Dr. Jamie Hardy: The Lifestyle Pharmacist

I’ve always been a go-getter so being still mentally and physically is something that I’ve always struggled with. The thing is, I’ve come to acknowledge and accept that being in “go mode” all the time isn’t healthy for me. The fast and high-pressure pace can lead to burnout. Slowing down is definitely something that I’m working on. That’s why I jumped at the opportunity to go on a weeklong vacation to Belize.

article thumbnail

CMS: Medicare Advantage plans with 4 or more stars skyrocket in 2022 compared to 2021

Fierce Healthcare

CMS: Medicare Advantage plans with 4 or more stars skyrocket in 2022 compared to 2021. rking. Fri, 10/08/2021 - 12:12.

134
134